Cashing in on coronavirus: Small biopharma company NanoViricides sees stock soar on treatment claims
July 14, 2020 at 07:00 AM EDT
As the coronavirus was spreading in China, a small biopharma company, NanoViricides, claimed it was close to clinical trials for a treatment. A CNBC investigation found the 15-year-old company has never tested a product in humans or made any revenue.
